Epalrestat
- Generic Name
- Epalrestat
- Drug Type
- Small Molecule
- Chemical Formula
- C15H13NO3S2
- CAS Number
- 82159-09-9
- Unique Ingredient Identifier
- 424DV0807X
Overview
Epalrestat is under investigation in clinical trial NCT03244358 (Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer).
Background
Epalrestat is under investigation in clinical trial NCT03244358 (Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer).
Indication
适用于糖尿病神经性病变。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath